Romano MR and Lograno MD |
Cannabinoid agonists induce relaxation in the bovine ophthalmic artery: evidences for CB1 receptors, nitric oxide and potassium channels. |
2006 |
Br. J. Pharmacol. |
pmid:16474412
|
GarcÃa Mdel C et al. |
Role of CGRP and GABA in the hypotensive effect of intrathecally administered anandamide to anesthetized rats. |
2006 |
Eur. J. Pharmacol. |
pmid:16472800
|
Cupini LM et al. |
Biochemical changes in endocannabinoid system are expressed in platelets of female but not male migraineurs. |
2006 |
Cephalalgia |
pmid:16472333
|
Glaser ST et al. |
Endocannabinoids in the intact retina: 3 H-anandamide uptake, fatty acid amide hydrolase immunoreactivity and hydrolysis of anandamide. |
2005 Nov-Dec |
Vis. Neurosci. |
pmid:16469181
|
Gough NR |
Focus issue: signaling lipids. |
2006 |
Sci. STKE |
pmid:16467192
|
Waku K |
[Endogenous cannabinoid receptor ligands--anandamide and 2-arachidonoylglycerol]. |
2006 |
Yakugaku Zasshi |
pmid:16462096
|
Kaczocha M et al. |
Anandamide uptake is consistent with rate-limited diffusion and is regulated by the degree of its hydrolysis by fatty acid amide hydrolase. |
2006 |
J. Biol. Chem. |
pmid:16461355
|
Tuccinardi T et al. |
Cannabinoid CB2/CB1 selectivity. Receptor modeling and automated docking analysis. |
2006 |
J. Med. Chem. |
pmid:16451064
|
Guindon J and Beaulieu P |
Antihyperalgesic effects of local injections of anandamide, ibuprofen, rofecoxib and their combinations in a model of neuropathic pain. |
2006 |
Neuropharmacology |
pmid:16442133
|
Ueda N and Tsuboi K |
[Enzymes involved in the biosynthesis and degradation of anandamide]. |
2005 |
Seikagaku |
pmid:16440755
|
Schelling G et al. |
Effects of general anesthesia on anandamide blood levels in humans. |
2006 |
Anesthesiology |
pmid:16436846
|
Murillo-Rodriguez E et al. |
Diurnal variation of arachidonoylethanolamine, palmitoylethanolamide and oleoylethanolamide in the brain of the rat. |
2006 |
Life Sci. |
pmid:16434061
|
Marx J |
Drug development. Drugs inspired by a drug. |
2006 |
Science |
pmid:16424309
|
Meuth SG et al. |
The contribution of TWIK-related acid-sensitive K+-containing channels to the function of dorsal lateral geniculate thalamocortical relay neurons. |
2006 |
Mol. Pharmacol. |
pmid:16424077
|
Guagnini F et al. |
Neural contractions in colonic strips from patients with diverticular disease: role of endocannabinoids and substance P. |
2006 |
Gut |
pmid:16423891
|
Bermúdez-Siva FJ et al. |
Activation of cannabinoid CB1 receptors induces glucose intolerance in rats. |
2006 |
Eur. J. Pharmacol. |
pmid:16423347
|
Kohro S et al. |
Anandamide absorption by direct hemoperfusion with polymixin B-immobilized fiber improves the prognosis and organ failure assessment score in patients with sepsis. |
2006 |
J Anesth |
pmid:16421670
|
Salo OM et al. |
3D-QSAR studies on cannabinoid CB1 receptor agonists: G-protein activation as biological data. |
2006 |
J. Med. Chem. |
pmid:16420041
|
Siegmund SV et al. |
Fatty acid amide hydrolase determines anandamide-induced cell death in the liver. |
2006 |
J. Biol. Chem. |
pmid:16418162
|
Voets T et al. |
Sensing with TRP channels. |
2005 |
Nat. Chem. Biol. |
pmid:16408004
|
Yang YY et al. |
Roles of anandamide in the hepatic microcirculation in cirrhotic rats. |
2006 |
Am. J. Physiol. Gastrointest. Liver Physiol. |
pmid:16407591
|
Appendino G et al. |
First "hybrid" ligands of vanilloid TRPV1 and cannabinoid CB2 receptors and non-polyunsaturated fatty acid-derived CB2-selective ligands. |
2006 |
FEBS Lett. |
pmid:16406364
|
Nakajima Y et al. |
Endocannabinoid, anandamide in gingival tissue regulates the periodontal inflammation through NF-kappaB pathway inhibition. |
2006 |
FEBS Lett. |
pmid:16406050
|
D'Argenio G et al. |
Up-regulation of anandamide levels as an endogenous mechanism and a pharmacological strategy to limit colon inflammation. |
2006 |
FASEB J. |
pmid:16403786
|
Eljaschewitsch E et al. |
The endocannabinoid anandamide protects neurons during CNS inflammation by induction of MKP-1 in microglial cells. |
2006 |
Neuron |
pmid:16387640
|
Bai X et al. |
TASK channel expression in human placenta and cytotrophoblast cells. |
2006 |
J. Soc. Gynecol. Investig. |
pmid:16378911
|
Ligresti A et al. |
Endocannabinoid metabolic pathways and enzymes. |
2005 |
Curr Drug Targets CNS Neurol Disord |
pmid:16375679
|
Bojesen IN and Hansen HS |
Effect of an unstirred layer on the membrane permeability of anandamide. |
2006 |
J. Lipid Res. |
pmid:16365480
|
Gobbi G et al. |
Antidepressant-like activity and modulation of brain monoaminergic transmission by blockade of anandamide hydrolysis. |
2005 |
Proc. Natl. Acad. Sci. U.S.A. |
pmid:16352709
|
Varvel SA et al. |
Fatty acid amide hydrolase (-/-) mice exhibit an increased sensitivity to the disruptive effects of anandamide or oleamide in a working memory water maze task. |
2006 |
J. Pharmacol. Exp. Ther. |
pmid:16352706
|
Siegmund SV and Brenner DA |
Molecular pathogenesis of alcohol-induced hepatic fibrosis. |
2005 |
Alcohol. Clin. Exp. Res. |
pmid:16344593
|
Grimaldi C et al. |
Anandamide inhibits adhesion and migration of breast cancer cells. |
2006 |
Exp. Cell Res. |
pmid:16343481
|
Lizanecz E et al. |
Phosphorylation-dependent desensitization by anandamide of vanilloid receptor-1 (TRPV1) function in rat skeletal muscle arterioles and in Chinese hamster ovary cells expressing TRPV1. |
2006 |
Mol. Pharmacol. |
pmid:16338989
|
Flygare J et al. |
Cannabinoid receptor ligands mediate growth inhibition and cell death in mantle cell lymphoma. |
2005 |
FEBS Lett. |
pmid:16337199
|
Hejazi N et al. |
Delta9-tetrahydrocannabinol and endogenous cannabinoid anandamide directly potentiate the function of glycine receptors. |
2006 |
Mol. Pharmacol. |
pmid:16332990
|
Rösch S et al. |
R(+)-methanandamide and other cannabinoids induce the expression of cyclooxygenase-2 and matrix metalloproteinases in human nonpigmented ciliary epithelial cells. |
2006 |
J. Pharmacol. Exp. Ther. |
pmid:16330497
|
Cannizzaro C et al. |
Presynaptic effects of anandamide and WIN55,212-2 on glutamatergic nerve endings isolated from rat hippocampus. |
2006 |
Neurochem. Int. |
pmid:16325966
|
Juan-Picó P et al. |
Cannabinoid receptors regulate Ca(2+) signals and insulin secretion in pancreatic beta-cell. |
2006 |
Cell Calcium |
pmid:16321437
|
Suplita RL et al. |
Endocannabinoids at the spinal level regulate, but do not mediate, nonopioid stress-induced analgesia. |
2006 |
Neuropharmacology |
pmid:16316669
|
Mechoulam R and Deutsch DG |
Toward an anandamide transporter. |
2005 |
Proc. Natl. Acad. Sci. U.S.A. |
pmid:16314567
|
Bir LS and Ercan S |
Effects of intrathecal anandamide on somatosensory evoked responses in rats. |
2006 |
Exp. Neurol. |
pmid:16289169
|
Ligresti A et al. |
New potent and selective inhibitors of anandamide reuptake with antispastic activity in a mouse model of multiple sclerosis. |
2006 |
Br. J. Pharmacol. |
pmid:16284631
|
Brizzi A et al. |
Design, synthesis, and binding studies of new potent ligands of cannabinoid receptors. |
2005 |
J. Med. Chem. |
pmid:16279794
|
Glaser ST et al. |
Ex vivo imaging of fatty acid amide hydrolase activity and its inhibition in the mouse brain. |
2006 |
J. Pharmacol. Exp. Ther. |
pmid:16278311
|
Kadoi Y et al. |
Cannabinoid antagonist AM 281 reduces mortality rate and neurologic dysfunction after cecal ligation and puncture in rats. |
2005 |
Crit. Care Med. |
pmid:16276190
|
Sarnataro D et al. |
Plasma membrane and lysosomal localization of CB1 cannabinoid receptor are dependent on lipid rafts and regulated by anandamide in human breast cancer cells. |
2005 |
FEBS Lett. |
pmid:16263116
|
Kim HI et al. |
Anandamide suppression of Na+ currents in rat dorsal root ganglion neurons. |
2005 |
Brain Res. |
pmid:16256960
|
Cabranes A et al. |
Decreased endocannabinoid levels in the brain and beneficial effects of agents activating cannabinoid and/or vanilloid receptors in a rat model of multiple sclerosis. |
2005 |
Neurobiol. Dis. |
pmid:16242629
|
Di S et al. |
Activity-dependent release and actions of endocannabinoids in the rat hypothalamic supraoptic nucleus. |
2005 |
J. Physiol. (Lond.) |
pmid:16239276
|
Malfitano AM et al. |
Arvanil inhibits T lymphocyte activation and ameliorates autoimmune encephalomyelitis. |
2006 |
J. Neuroimmunol. |
pmid:16239036
|
Jiang W et al. |
Cannabinoids promote embryonic and adult hippocampus neurogenesis and produce anxiolytic- and antidepressant-like effects. |
2005 |
J. Clin. Invest. |
pmid:16224541
|
Van Sickle MD et al. |
Identification and functional characterization of brainstem cannabinoid CB2 receptors. |
2005 |
Science |
pmid:16224028
|
Urbani P et al. |
New metabolically stable fatty acid amide ligands of cannabinoid receptors: Synthesis and receptor affinity studies. |
2006 |
Bioorg. Med. Chem. Lett. |
pmid:16213718
|
Thomas A et al. |
Evidence that the plant cannabinoid Delta9-tetrahydrocannabivarin is a cannabinoid CB1 and CB2 receptor antagonist. |
2005 |
Br. J. Pharmacol. |
pmid:16205722
|
Mechoulam R |
Plant cannabinoids: a neglected pharmacological treasure trove. |
2005 |
Br. J. Pharmacol. |
pmid:16205721
|
Tzavara ET et al. |
Endocannabinoids activate transient receptor potential vanilloid 1 receptors to reduce hyperdopaminergia-related hyperactivity: therapeutic implications. |
2006 |
Biol. Psychiatry |
pmid:16199010
|
Singh Tahim A et al. |
Inflammatory mediators convert anandamide into a potent activator of the vanilloid type 1 transient receptor potential receptor in nociceptive primary sensory neurons. |
2005 |
Neuroscience |
pmid:16198486
|
Li C et al. |
High affinity electrophilic and photoactivatable covalent endocannabinoid probes for the CB1 receptor. |
2005 |
J. Med. Chem. |
pmid:16190768
|
Schmidt A et al. |
Determination of the endocannabinoid anandamide in human plasma by high-performance liquid chromatography. |
2006 |
Biomed. Chromatogr. |
pmid:16189813
|
Engeli S et al. |
Activation of the peripheral endocannabinoid system in human obesity. |
2005 |
Diabetes |
pmid:16186383
|
Battista N et al. |
Endocannabinoids and their involvement in the neurovascular system. |
2004 |
Curr Neurovasc Res |
pmid:16185189
|
Straiker A and Mackie K |
Depolarization-induced suppression of excitation in murine autaptic hippocampal neurones. |
2005 |
J. Physiol. (Lond.) |
pmid:16179366
|
Bazinet RP et al. |
Rapid high-energy microwave fixation is required to determine the anandamide (N-arachidonoylethanolamine) concentration of rat brain. |
2005 |
Neurochem. Res. |
pmid:16176062
|
Barun S et al. |
Effects of cannabinoid receptor activation on rabbit bisected vas deferens strips. |
2005 |
Clin. Exp. Pharmacol. Physiol. |
pmid:16173925
|
Underdown NJ et al. |
Anandamide reduces infarct size in rat isolated hearts subjected to ischaemia-reperfusion by a novel cannabinoid mechanism. |
2005 |
Br. J. Pharmacol. |
pmid:16158067
|
Sun YX et al. |
Involvement of N-acylethanolamine-hydrolyzing acid amidase in the degradation of anandamide and other N-acylethanolamines in macrophages. |
2005 |
Biochim. Biophys. Acta |
pmid:16154384
|
Gasperi V et al. |
Further insights into the regulation of human FAAH by progesterone and leptin implications for endogenous levels of anandamide and apoptosis of immune and neuronal cells. |
2005 |
Neurotoxicology |
pmid:16154199
|
Yang W et al. |
Enzymatic formation of prostamide F2alpha from anandamide involves a newly identified intermediate metabolite, prostamide H2. |
2005 |
J. Lipid Res. |
pmid:16150817
|
Hayase T et al. |
Persistent anxiogenic effects of a single or repeated doses of cocaine and methamphetamine: interactions with endogenous cannabinoid receptor ligands. |
2005 |
Behav Pharmacol |
pmid:16148444
|
Sancho R et al. |
Mechanisms of HIV-1 inhibition by the lipid mediator N-arachidonoyldopamine. |
2005 |
J. Immunol. |
pmid:16148147
|
Wang Y et al. |
VR1-mediated depressor effects during high-salt intake: role of anandamide. |
2005 |
Hypertension |
pmid:16144988
|
Maccarrone M et al. |
Characterization of the endocannabinoid system in boar spermatozoa and implications for sperm capacitation and acrosome reaction. |
2005 |
J. Cell. Sci. |
pmid:16144868
|
Kopczyńska B and Szereda-Przestaszewska M |
Supranodose vagotomy eliminates anandamide-evoked cardiorespiratory depression in anaesthetized rats. |
2006 |
Respir Physiol Neurobiol |
pmid:16144778
|
Matsuda K et al. |
The cannabinoid 1 receptor antagonist, AM251, prolongs the survival of rats with severe acute pancreatitis. |
2005 |
Tohoku J. Exp. Med. |
pmid:16141678
|
Valenti M et al. |
The endocannabinoid system in the brain of Carassius auratus and its possible role in the control of food intake. |
2005 |
J. Neurochem. |
pmid:16135090
|
Osei-Hyiaman D et al. |
Cocaine- and amphetamine-related transcript is involved in the orexigenic effect of endogenous anandamide. |
2005 |
Neuroendocrinology |
pmid:16131814
|
Suplita RL et al. |
Inhibition of fatty-acid amide hydrolase enhances cannabinoid stress-induced analgesia: sites of action in the dorsolateral periaqueductal gray and rostral ventromedial medulla. |
2005 |
Neuropharmacology |
pmid:16129456
|
Schuel H and Burkman LJ |
A tale of two cells: endocannabinoid-signaling regulates functions of neurons and sperm. |
2005 |
Biol. Reprod. |
pmid:16120829
|
McPartland JM et al. |
Cannabimimetic effects of osteopathic manipulative treatment. |
2005 |
J Am Osteopath Assoc |
pmid:16118355
|
Wagner JA et al. |
Coronary vasodilator effects of endogenous cannabinoids in vasopressin-preconstricted unpaced rat isolated hearts. |
2005 |
J. Cardiovasc. Pharmacol. |
pmid:16116341
|
van der Stelt M et al. |
Anandamide acts as an intracellular messenger amplifying Ca2+ influx via TRPV1 channels. |
2005 |
EMBO J. |
pmid:16107881
|
Sade H et al. |
Activation of large-conductance, Ca2+-activated K+ channels by cannabinoids. |
2006 |
Am. J. Physiol., Cell Physiol. |
pmid:16107501
|
Yoshihara S et al. |
Endogenous cannabinoid receptor agonists inhibit neurogenic inflammations in guinea pig airways. |
2005 |
Int. Arch. Allergy Immunol. |
pmid:16103691
|
Patsos HA et al. |
The endogenous cannabinoid, anandamide, induces cell death in colorectal carcinoma cells: a possible role for cyclooxygenase 2. |
2005 |
Gut |
pmid:16099783
|
van der Stelt M and Di Marzo V |
Anandamide as an intracellular messenger regulating ion channel activity. |
2005 |
Prostaglandins Other Lipid Mediat. |
pmid:16099396
|
Besana A et al. |
Lipids and two-pore domain K+ channels in excitable cells. |
2005 |
Prostaglandins Other Lipid Mediat. |
pmid:16099395
|
Poblete IM et al. |
Anandamide elicits an acute release of nitric oxide through endothelial TRPV1 receptor activation in the rat arterial mesenteric bed. |
2005 |
J. Physiol. (Lond.) |
pmid:16081483
|
Movahed P et al. |
Endogenous unsaturated C18 N-acylethanolamines are vanilloid receptor (TRPV1) agonists. |
2005 |
J. Biol. Chem. |
pmid:16081411
|
Lambert DM and Fowler CJ |
The endocannabinoid system: drug targets, lead compounds, and potential therapeutic applications. |
2005 |
J. Med. Chem. |
pmid:16078824
|
Lee MG et al. |
Effect of olvanil and anandamide on vagal C-fiber subtypes in guinea pig lung. |
2005 |
Br. J. Pharmacol. |
pmid:16056239
|
Kraft B and Kress HG |
Indirect CB2 receptor and mediator-dependent stimulation of human whole-blood neutrophils by exogenous and endogenous cannabinoids. |
2005 |
J. Pharmacol. Exp. Ther. |
pmid:16055676
|
Wahn H et al. |
The endocannabinoid arachidonyl ethanolamide (anandamide) increases pulmonary arterial pressure via cyclooxygenase-2 products in isolated rabbit lungs. |
2005 |
Am. J. Physiol. Heart Circ. Physiol. |
pmid:16055511
|
Yamaguchi Y et al. |
[Surgical stress]. |
2005 |
Nihon Geka Gakkai Zasshi |
pmid:16045189
|
Lynch DL and Reggio PH |
Molecular dynamics simulations of the endocannabinoid N-arachidonoylethanolamine (anandamide) in a phospholipid bilayer: probing structure and dynamics. |
2005 |
J. Med. Chem. |
pmid:16033262
|
Gaskari SA et al. |
Role of endocannabinoids in the pathogenesis of cirrhotic cardiomyopathy in bile duct-ligated rats. |
2005 |
Br. J. Pharmacol. |
pmid:16025138
|
Solbrig MV et al. |
A role for endocannabinoids in viral-induced dyskinetic and convulsive phenomena. |
2005 |
Exp. Neurol. |
pmid:16022863
|
Awumey EM et al. |
Is there a role for anandamide in cardiovascular regulation? Insights from studies of endocannabinoid metabolism. |
2005 |
Am. J. Physiol. Heart Circ. Physiol. |
pmid:16014613
|
de Lago E et al. |
UCM707, an inhibitor of the anandamide uptake, behaves as a symptom control agent in models of Huntington's disease and multiple sclerosis, but fails to delay/arrest the progression of different motor-related disorders. |
2006 |
Eur Neuropsychopharmacol |
pmid:16006105
|
Movahed P et al. |
Vascular effects of anandamide and N-acylvanillylamines in the human forearm and skin microcirculation. |
2005 |
Br. J. Pharmacol. |
pmid:15997233
|
Taddei S |
Evolving the concept of regulation of vascular tone in humans. |
2005 |
Br. J. Pharmacol. |
pmid:15997231
|